National Research (NASDAQ:NRC) Hits New 12-Month High – Should You Buy?

National Research Corporation (NASDAQ:NRC) hit a new 52-week high during trading on Friday . The stock traded as high as $22.16 and last traded at $22.0950, with a volume of 52850 shares trading hands. The stock had previously closed at $21.30.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

National Research Stock Performance

The stock has a fifty day moving average price of $17.70 and a 200 day moving average price of $15.46. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 5.31. The firm has a market cap of $503.51 million, a price-to-earnings ratio of 31.74 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Monday, October 27th. The company reported $0.23 EPS for the quarter. National Research had a return on equity of 98.26% and a net margin of 11.76%.The company had revenue of $34.61 million for the quarter.

Institutional Investors Weigh In On National Research

A number of hedge funds have recently bought and sold shares of NRC. Significant Wealth Partners LLC lifted its position in shares of National Research by 5.4% during the 3rd quarter. Significant Wealth Partners LLC now owns 15,268 shares of the company’s stock worth $195,000 after purchasing an additional 776 shares during the last quarter. M&T Bank Corp increased its position in National Research by 6.4% in the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after buying an additional 823 shares during the period. Sei Investments Co. lifted its holdings in shares of National Research by 1.2% during the third quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock worth $975,000 after buying an additional 900 shares during the last quarter. Russell Investments Group Ltd. boosted its position in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after acquiring an additional 921 shares during the period. Finally, Rhumbline Advisers grew its stake in shares of National Research by 4.5% in the first quarter. Rhumbline Advisers now owns 22,204 shares of the company’s stock worth $284,000 after acquiring an additional 946 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.